2m 2m 2m 2m 2m 2m 2m
PALVELLA THERA (PVLA)
NASDAQ
$146.17+$0.14 (+0.10%)
Price as of Jul 14, 2026 4:15 AM EDT- $2.1BMarket Cap
- 430.05%1-Year Change
- BiotechnologyIndustry
PALVELLA THERA (PVLA)
$146.17+$0.14 (+0.10%)
PVLA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $146.03 | ||
Change | +$1.27 (+0.88%) | ||
Open | $142.11 | ||
High | $146.35 | ||
Low | $137.37 | ||
Previous Close | $144.76 | ||
Volume | 209,781 | ||
30-Day Average Volume | 315,958 | ||
1-Week Change | 4.08% | ||
1-Month Change | 34.21% | ||
1-Year Change | 430.05% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.3M | ||
Total Assets | $263.8M | ||
Market Cap | $2.1B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$15.8M | ||
Free Cash Flow | -$10.9M | ||
EBIT | -$15.8M | ||
EBITDA | -$15.8M | ||
Net Working Capital | $254.1M | ||
EPS | -$1.20 | ||
Enterprise Value/EBITDA | -119 | ||
Enterprise Value/Revenue | 1,736 | ||
P/B | 9 | ||
P/E | -121 | ||
PEG | 10 | ||
Price/Free Cash Flow | -191 | ||
Price/Operating Cash Flow | -191 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue